Short Interest in NeueHealth, Inc. (NYSE:NEUE) Increases By 33.7%

NeueHealth, Inc. (NYSE:NEUE) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 12,300 shares, a growth of 33.7% from the February 28th total of 9,200 shares. Currently, 0.5% of the shares of the company are short sold. Based on an average daily volume of 47,300 shares, the short-interest ratio is currently 0.3 days.

Insider Transactions at NeueHealth

In other news, CEO George Lawrence Mikan III sold 12,440 shares of the business’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $6.13, for a total transaction of $76,257.20. Following the transaction, the chief executive officer now owns 249,454 shares in the company, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jay Matushak sold 4,970 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10. Following the transaction, the chief financial officer now directly owns 17,747 shares of the company’s stock, valued at $130,085.51. This represents a 21.88 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 110,033 shares of company stock worth $774,560. Company insiders own 64.30% of the company’s stock.

Institutional Trading of NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. Virtu Financial LLC bought a new position in NeueHealth, Inc. (NYSE:NEUE) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned about 0.12% of NeueHealth as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 63.88% of the company’s stock.

NeueHealth Stock Up 1.2 %

NEUE traded up $0.08 during trading on Wednesday, reaching $6.68. 4,063 shares of the company’s stock were exchanged, compared to its average volume of 19,924. The company has a market capitalization of $55.34 million, a P/E ratio of -0.13 and a beta of 0.56. The business has a 50 day moving average price of $6.92 and a 200 day moving average price of $6.09. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $7.66.

NeueHealth (NYSE:NEUE) last posted its quarterly earnings results on Thursday, March 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.29) by ($5.12). The business had revenue of $232.64 million during the quarter, compared to analyst estimates of $261.80 million. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. As a group, research analysts forecast that NeueHealth will post -9.13 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada cut their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.